Apremilast efficacy and safety in elderly psoriasis patients over a 48-week period.

Megna, M; Fabbrocini, G; Camela, E; Cinelli, E

Megna, M; Fabbrocini, G; Camela, E; Cinelli, E.

Affiliation

Megna M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Camela E; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Cinelli E; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

J Eur Acad Dermatol Venereol ; 34(11): e705-e707, 2020 Nov.

Article in En | MEDLINE | ID: mdl-32277507

Subject(s)

Psoriasis; Thalidomide; Aged; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Humans; Psoriasis/drug therapy; Severity of Illness Index; Thalidomide/analogs & derivatives; Thalidomide/therapeutic use; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Thalidomide Limits: Aged / Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2020 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google